Fundraising Fox
Ena Respiratory
Melbourne, AU · Founded 2020 · 9 employees on LinkedIn · 3 known investors
Find your way into Ena Respiratory
Each arrow is one introduction. Sign up to fill in the first one.
137 people can intro you to Christophe
Ask John Kurek to introduce you to Christophe Demaison
You →John · together at Ena Respiratory →Christophe
Sign up to find every way you can get introduced to Ena Respiratory
- Your email: who you already know at Ena Respiratory, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Ena Respiratory team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
ENA Respiratory develops and brings respiratory treatments to market across the US and other regions. The company operates at the intersection of pharmaceutical product development and clinical innovation, with deep expertise in bringing early-stage respiratory therapies through development and regulatory approval.
Founders & leadership
CD
Christophe DemaisonCEOChristophe Demaison is CEO of Ena Respiratory, which develops and brings respiratory treatments through regulatory approval and to market in the US and other regions. He has experience in life sciences ventures, capital raising, and strategic partnerships in pharmaceutical and biotech sectors.
Investors · 3
Frequently asked questions
- What does Ena Respiratory do?
- ENA Respiratory develops and brings respiratory treatments to market across the US and other regions. The company operates at the intersection of pharmaceutical product development and clinical innovation, with deep expertise in bringing early-stage respiratory therapies through development and regulatory approval.
- Who are Ena Respiratory's investors?
- Ena Respiratory's investors include Brandon BioCatalyst, Stoic VC, UniSeed Pty Ltd..
- Where is Ena Respiratory headquartered?
- Ena Respiratory is headquartered in Melbourne, AU.